{"resourceType": "EvidenceVariable", "url": "https://fevir.net/resources/EvidenceVariable/346490", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "urn:ietf:rfc:3986", "value": "https://fevir.net/FOI/346490", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "CTIS2024-516402-32-00 Secondary Outcome 3", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "CTIS endPoint id"}, "value": 441511}], "name": "CTIS2024_516402_32_00_Secondary_Outcome_3", "title": "CTIS2024-516402-32-00 Secondary Outcome 3", "status": "active", "description": "Renal replacement therapy rates at months 3 and 12 follow-up", "meta": {"versionId": "1", "lastUpdated": "2025-03-05T18:20:38.916Z"}, "id": "346490", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Brian S. Alper, MD, MSPH"}]}